Reduction of adverse effects of indomethacin by anti-allergic drugs in rat stomachs.

Abstract

This study was designed to elucidate the role of leukotrienes (LT) in indomethacin-induced gastric ulcers in relation to effects of clinically available anti-allergic drugs, azelastine (Azeptin, CAS 58581-89-8) and oxatomide (CAS 60607-34-3). Azelastine (2 mg/kg) or oxatomide (30 mg/kg) was administered intragastrically once 15 min before intragastrical administration of 12 mg/kg of indomethacin. Mucosal prostaglandins (PGs) and LTs were measured by high-performance liquid chromatography (HPLC). In the control rats, 4 kinds of PGs, i.e., 6-keto-PGF1 alpha, PGF2 alpha, PGE2 and PGD2, were detected in gastric mucosa, but no LT was detected. Administration of indomethacin caused severe gastric ulcers (lesion scores; 31.2 +/- 11.1 mm), and all prostaglandins were diminished completely. In contrast, LTC4 and LTD4 (peptide-LTs) were detected and the sum of their levels was 18.5 +/- 7.1 ng/g tissue. Irrespective of indomethacin administration, lesion scores were remarkably reduced in rats treated with azelastine or oxatomide (17.0 +/- 8.1 and 16.0 +/- 8.0, respectively). Azelastine and oxatomide treatment did not improve mucosal PG levels, however, both drugs reduced significantly increases in peptide-LT level, 9.3 +/- 4.6 and 8.6 +/- 4.4, respectively. These results suggest that increases in mucosal LT levels are also involved in the formation of indomethacin-induced gastric ulcers. Combined therapy using anti-allergic drugs and non-steroidal anti-inflammatory drugs might be recommended.

050100150'01'03'05'07'09'11'13'15'17
Citations per Year

180 Citations

Semantic Scholar estimates that this publication has 180 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ohara1992ReductionOA, title={Reduction of adverse effects of indomethacin by anti-allergic drugs in rat stomachs.}, author={Akira Ohara and Sumio Sugiyama and Hideaki Hoshino and Eiji Hamajima and H Goto and Yasuhiro Tsukamoto and Takuya Ozawa}, journal={Arzneimittel-Forschung}, year={1992}, volume={42 9}, pages={1115-8} }